filings.toolsItem 2. PROPERTIES
3K characters. Original on sec.gov · Markdown
Item 2. PROPERTIES
Our corporate headquarters are located at 530 Herman O. West Drive, Exton, Pennsylvania. This building also houses our North American sales and marketing, administrative support and customer service functions, as well as laboratories.
The following table summarizes production facilities by segment and geographic region. All facilities shown are owned except where otherwise noted.
| Proprietary Products | ||||
| Manufacturing: | ||||
| North American Operations | European Operations | Asia Pacific Operations | ||
| United States | Denmark | China | ||
| Clearwater, FL | Horsens | Qingpu | ||
| Jersey Shore, PA | England | India | ||
| Kearney, NE | St. Austell | Sri City | ||
| Kinston, NC | France | Singapore | ||
| Lititz, PA | Le Nouvion | Jurong | ||
| Scottsdale, AZ (2) | Le Vaudreuil | |||
| St. Petersburg, FL (1) | Germany | |||
| Eschweiler (1) | ||||
| South American Operations | Stolberg | |||
| Brazil | Serbia | |||
| Sao Paulo | Kovin | |||
| Mold-and-Die Tool Shop: | Contract Analytical Laboratory: | |||
| North American Operations | European Operations | North American Operations | ||
| United States | England | United States | ||
| Upper Darby, PA | Bodmin (2) | Exton, PA | ||
| Contract-Manufactured Products | ||||
| Manufacturing: | ||||
| North American Operations | European Operations | |||
| United States | Ireland | |||
| Frankfort, IN (2) | Dublin (2) | |||
| Grand Rapids, MI | ||||
| Phoenix, AZ (2) | ||||
| Tempe, AZ (2) | ||||
| Williamsport, PA | ||||
| Puerto Rico | ||||
| Cayey | ||||
| (1) | This manufacturing facility is also used for research and development activities. |
| (2) | This facility is leased in whole or in part. |
Our Proprietary Products reportable segment leases facilities located in Israel, New Jersey and Texas for research and development, as well as other activities. Sales offices in various locations are leased under short-term arrangements.
In October 2014, we announced plans to expand our global manufacturing operations to include a new facility in Waterford, Ireland, which will produce packaging components for insulin injector cartridges and other high-value packaging components. Commercial production is expected to begin in 2018.
Previous: Item 1A. RISK FACTORS · Next: Item 3. LEGAL PROCEEDINGS